Carbonic anhydrase inhibitory compounds which incorporate a 4-sulfamoylphenylmethylthiourea scaffold are disclosed. The new compounds show strong affinities toward carbonic anhydrase isozymes I, II and IV and produce effective and prolonged reduction in intraocular pressure following topical ocular administration. The compounds are useful in treating glaucoma or ocular hypertension.
抑制性
碳酸酐酶化合物,其中包括4-
磺胺基苯甲基
硫脲骨架。这些新化合物对
碳酸酐酶同工酶I、II和IV具有很强的亲和力,并在局部眼用给药后产生有效且持久的降低眼压作用。这些化合物可用于治疗青光眼或眼压增高。